HEPATOLOGY Podcast podkast

Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection

0:00
10:41
Do tyłu o 15 sekund
Do przodu o 15 sekund
Note: Published earlier in 2015. Drs. Stephen A. Harrison and Saleh A. Alqahtani discuss the paper: Safety and Tolerability of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Phase III ION Trials.

Więcej odcinków z kanału "HEPATOLOGY Podcast"